Director CHU YI-AN discloses 2,000 RSUs in Apollomics (APLM)

Rhea-AI Filing Summary

Apollomics Inc. director CHU YI-AN reported initial beneficial ownership consisting of restricted stock units linked to Class A Ordinary Shares. The filing shows 2,000 underlying shares associated with these restricted stock units. According to the vesting terms, 500 units vested on February 9, 2026, with additional 500-unit tranches vesting on March 15, 2026, June 15, 2026 and September 15, 2026. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider CHU YI-AN

Role Director

Type	Security	Shares	Price	Value
holding	Restricted Stock Units	--	--	--

Holdings After Transaction: Restricted Stock Units — 2,000 shares (Direct)

Footnotes (1)

1. The restricted stock units were vested with respect to 500 shares upon grant on February 9, 2026, with an additional 500 shares vesting on each of March 15, 2026, June 15, 2026 and September 15, 2026. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

CHU YI-AN

(Last) (First) (Middle)

989 E HILLSDALE BLVD, SUITE 220

(Street)

FOSTER CITY 94404

(City) (State) (Zip)

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Apollomics Inc. [ APLM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	(1)	Class A Ordinary Shares	2,000	(2)	D

Explanation of Responses:

1. The restricted stock units were vested with respect to 500 shares upon grant on February 9, 2026, with an additional 500 shares vesting on each of March 15, 2026, June 15, 2026 and September 15, 2026.

2. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share.

Remarks:

This Initial Statement of Beneficial Ownership is being filed in connection with the enactment of the Holding Foreign Insiders Accountable Act and the rules and regulations adopted in association therewith.

	/s/ Chu, Yi-An	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Apollomics (APLM) Form 3 for CHU YI-AN report?

The Form 3 reports CHU YI-AN’s initial beneficial ownership in Apollomics through restricted stock units tied to Class A Ordinary Shares. It discloses a position of 2,000 underlying shares, along with detailed vesting terms for these equity awards over several specified 2026 dates.

How many Apollomics (APLM) restricted stock units does CHU YI-AN hold?

CHU YI-AN is reported as holding restricted stock units corresponding to 2,000 underlying Class A Ordinary Shares of Apollomics. This figure reflects the total underlying shares linked to the award, providing a clear view of the director’s equity-based stake as disclosed in the Form 3.

What is the vesting schedule for CHU YI-AN’s Apollomics (APLM) RSUs?

The restricted stock units vested with respect to 500 shares on February 9, 2026. Additional 500-share tranches vest on March 15, 2026, June 15, 2026 and September 15, 2026. This staged vesting schedule spreads the equity award over four dates across 2026, as specified.

What does each Apollomics (APLM) restricted stock unit represent?

Each restricted stock unit represents a contingent right to receive one Apollomics Class A Ordinary Share. This means that, upon vesting and settlement, each unit can deliver a single share, aligning the director’s compensation with the company’s equity performance over time.

Does this Apollomics (APLM) Form 3 show any share purchases or sales?

The Form 3 presents a holding entry for restricted stock units and does not list any purchases or sales. Transaction summaries show no buy or sell activity, focusing instead on the existing 2,000-share RSU position and its vesting schedule rather than market trades.